WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Earnings & Revenue

LXEO past revenue growth

How has LXEO's revenue growth performed historically?
Company
-100%
Industry
89.08%
Market
19.74%
LXEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LXEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

LXEO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$69.4M
Current Profit Margin
0%

LXEO Return on Equity

Insufficient data to display

Be the first to know when LXEO announces earnings.

LXEO Return on Assets

Current Company
-58.7%
Current Industry
3.2%
LXEO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LXEO Return on Capital Employed

Current Company
-36.14%
Current Industry
-42.4%

LXEO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LXEO$0.00N/A-$69.42M-100.00%N/A
TRDA$162.87M$43.74M$23.49M+544.79%N/A
MREON/AN/AN/AN/AN/A
ITOS$0.00-$129.70M-$135.31M-100.00%N/A
PHAR$277.81M$8.15M-$11.60M+57.08%N/A

Lexeo Therapeutics Earnings & Revenue FAQ

What were LXEO's earnings last quarter?

Lexeo Therapeutics (NASDAQ: LXEO) reported Q1 2024 earnings per share (EPS) of -$0.77, up 93.35% year over year. Total Lexeo Therapeutics earnings for the quarter were -$21.68 million. In the same quarter last year, Lexeo Therapeutics's earnings per share (EPS) was -$11.58.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.

What was LXEO's earnings growth in the past year?

As of Q3 2024, Lexeo Therapeutics's earnings has grown year over year. Lexeo Therapeutics's earnings in the past year totalled -$69.42 million.

What was LXEO's revenue last quarter?

Lexeo Therapeutics (NASDAQ: LXEO) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Lexeo Therapeutics's revenue was $0.00.

What was LXEO's revenue growth in the past year?

As of Q3 2024, Lexeo Therapeutics's revenue has grown -100% year over year. This is 189.08 percentage points lower than the US Biotechnology industry revenue growth rate of 89.08%. Lexeo Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.